TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
61 hedge funds and large institutions have $101M invested in Taro Pharmaceutical Industries Ltd. in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% less capital invested
Capital invested by funds: $105M → $101M (-$4.33M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Holders
61
Holding in Top 10
1
Calls
–
Puts
$9K
Top Buyers
| 1 | +$1.19M | |
| 2 | +$777K | |
| 3 | +$482K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$342K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$333K |
Top Sellers
| 1 | -$1.75M | |
| 2 | -$1.75M | |
| 3 | -$332K | |
| 4 |
Renaissance Technologies
New York
|
-$302K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$269K |